NGNE has 36-month beta value of 1.36. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NGNE is 11.51M, and currently, short sellers hold a 8.58% ratio of that float. The average trading volume of NGNE on April 30, 2024 was 138.72K shares.
NGNE) stock’s latest price update
Neurogene Inc (NASDAQ: NGNE)’s stock price has gone rise by 11.48 in comparison to its previous close of 29.96, however, the company has experienced a 9.11% increase in its stock price over the last five trading days.
NGNE’s Market Performance
Neurogene Inc (NGNE) has seen a 9.11% rise in stock performance for the week, with a -34.38% decline in the past month and a 4.38% surge in the past quarter. The volatility ratio for the week is 6.34%, and the volatility levels for the past 30 days are at 6.94% for NGNE. The simple moving average for the past 20 days is -9.58% for NGNE’s stock, with a 48.73% simple moving average for the past 200 days.
Analysts’ Opinion of NGNE
William Blair, on the other hand, stated in their research note that they expect to see NGNE reach a price target of $61. The rating they have provided for NGNE stocks is “Outperform” according to the report published on March 21st, 2024.
H.C. Wainwright gave a rating of “Buy” to NGNE, setting the target price at $45 in the report published on January 08th of the current year.
NGNE Trading at -10.73% from the 50-Day Moving Average
After a stumble in the market that brought NGNE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -36.98% of loss for the given period.
Volatility was left at 6.94%, however, over the last 30 days, the volatility rate increased by 6.34%, as shares sank -28.60% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +11.33% upper at present.
During the last 5 trading sessions, NGNE rose by +9.11%, which changed the moving average for the period of 200-days by +95.30% in comparison to the 20-day moving average, which settled at $36.27. In addition, Neurogene Inc saw 72.34% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for NGNE
The total capital return value is set at -0.33. Equity return is now at value -25.91, with -21.46 for asset returns.
Based on Neurogene Inc (NGNE), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -19.59. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -2074.88.
Currently, EBITDA for the company is -49.36 million with net debt to EBITDA at 2.12. The liquidity ratio also appears to be rather interesting for investors as it stands at 8.72.
Conclusion
To put it simply, Neurogene Inc (NGNE) has had a better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
